Showing results (1891-1900 of 2,010) with videos related to

Sort By:
Pageof 201
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi = Chinese Journal of Schistosomiasis Control|November 13, 2019
[Protective effect of excretory-secretory protein from adult Trichinella spiralis on ovalbumin-induced allergic rhinitis in mice]Y Yuan, L Y Wang, J Mei, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate CancerDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
European Urology Focus|July 30, 2017
Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Journal of Cardiovascular Computed Tomography|March 26, 2026
Influence of computed tomography reconstruction algorithms on coronary artery calcium scores and reader agreementLee D Yang, Yosef A Cohen, Todd C Pulerwitz, et al.
Journal of Human Genetics|December 17, 2010
CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese childrenHo-Chang Kuo, Hong-Ren Yu, Suh-Hang Hank Juo, et al.
Journal of Surgical Oncology|May 1, 2023
Evaluation of emergency department treat-and-release encounters after major gastrointestinal surgeryBrian C Brajcich, Julie K Johnson, Jane L Holl, et al.
ESMO Open|July 26, 2024
Inhibitor of apoptosis proteins (IAP) inhibitor APG-1387 monotherapy or in combination with programmed cell death 1 (PD-1) inhibitor toripalimab in patients with advanced solid tumors: results from two phase I trialsF-R Liu, X-L Wei, W-N Feng, et al.
The New England Journal of Medicine|February 3, 2016
National Cluster-Randomized Trial of Duty-Hour Flexibility in Surgical TrainingKarl Y Bilimoria, Jeanette W Chung, Larry V Hedges, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Immune Spatial Organization Predicts Metastasis Risk in Aggressive Localized Prostate CancerDavid D Yang, Aya Abdelnaser, Jeremiah Wala, et al.
The Pharmacogenomics Journal|August 10, 2016
CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapyS Matsusaka, S Cao, D L Hanna, et al.
Pageof 201